Lemaitre Vascular (LMAT) Payables (2010 - 2026)

Lemaitre Vascular (LMAT) has reported Payables for 17 consecutive years, with $3.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Payables fell 34.15% year-over-year to $3.2 million in Q2 2026; TTM through Jun 2026 was $3.2 million, a 34.15% decrease from a year earlier, with the FY2025 full-year figure at $3.6 million, up 107.04% from the prior year.
• Payables was $3.2 million for Q2 2026 at Lemaitre Vascular, down from $4.2 million in the prior quarter.
• Over five years, Payables peaked at $4.9 million in Q2 2025 and troughed at $1.7 million in Q3 2024.
• A 5-year average of $3.1 million and a median of $3.2 million in 2024 frame the typical range for Payables.
• Across the five-year window, Payables tumbled 62.23% in 2024 and jumped 146.32% in 2025, its largest moves.
• Over 5 years, Payables stood at $2.9 million in 2022, then grew by 28.63% to $3.7 million in 2023, then sank by 52.84% to $1.8 million in 2024, then soared by 107.04% to $3.6 million in 2025, then declined by 11.25% to $3.2 million in 2026.
• The last three Payables figures came in at $3.2 million (Q2 2026), $4.2 million (Q1 2026), and $3.6 million (Q4 2025), per Business Quant data.